Previous close | 1.4800 |
Open | 1.3500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 20.00 |
Expiry date | 2024-08-16 |
Day's range | 1.3500 - 1.4800 |
Contract range | N/A |
Volume | |
Open interest | N/A |
ALAMEDA, Calif., May 28, 2024--Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4 at 4:20 p.m. ET / 3:20 p.m. CT / 1:20 p.m. PT in Chicago.
On May 21, 2024, Julie Smith, Director at Exelixis Inc (NASDAQ:EXEL), executed a sale of 27,280 shares of the company.
Exelixis (EXEL) resolves two patent litigations and grants Cipla a license to market generic versions of Cabometyx in the United States beginning January 2031.